Adient (ADNT) EBITDA (2015 - 2026)

Adient (ADNT) has reported EBITDA for 12 consecutive years, with $127.0 million the latest figure, recorded in Q1 2026.

• EBITDA for Q1 2026 came in at $127.0 million, up 158.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $455.0 million (up 350.5% YoY), and the FY2025 annual result was $115.0 million, down 66.47% from the prior year.
• EBITDA was $127.0 million for Q1 2026 at Adient, up from $90.0 million in the prior quarter.
• Over five years, EBITDA peaked at $173.0 million in Q2 2023 and troughed at -$216.0 million in Q1 2025.
• Average EBITDA over 5 years is $83.4 million, with a median of $111.0 million recorded in 2023.
• Year-over-year, EBITDA soared 394.29% in 2023 and slumped 2800.0% in 2025.
• Over 5 years, EBITDA stood at $114.0 million in 2022, then slipped by 2.63% to $111.0 million in 2023, then decreased by 16.22% to $93.0 million in 2024, then retreated by 3.23% to $90.0 million in 2025, then soared by 41.11% to $127.0 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $127.0 million in Q1 2026, $90.0 million in Q4 2025, and $120.0 million in Q3 2025.